HER2(EQ)BBzeta/CD19 T cells (City of Hope)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHER2(EQ)BBzeta/CD19 T cells (City of Hope)
Drug Alias NameHER2-targeting CAR T cells
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsT lymphocyte replacements
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMustang Bio IncCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesMustang Bio IncCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A